Clinical Trial Update: Fracture (FX) Improvement With Teriparatide: FiX-IT Study [Phase 4]

View source ↗

Summary

Phase 4 FiX-IT trial evaluated teriparatide for fracture improvement in patients with osteoporosis and atypical femoral fractures; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Femoral Fracture
• Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Susan L. Greenspan | Conditions: Osteoporosis, Atypical Femoral Fracture | Phase 4 | Status: COMPLETED | Results posted: 2017-12-12